In small cell lung cancer cells, SLFN11 expression is silenced by marked deposition of H3K27me3, leading to drug resistance, and is reactivated by inhibition of EZH2 a methyltransferase for H3K27 [24]. Here, EZH2 is linked to small cell lung carcinoma.